A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies

Author： Eder Jr Joseph P.   Garcia-Carbonero Rocio   Clark Jeffrey W.   Supko Jeffrey G.   Puchalski Thomas A.   Ryan David P.   Deluca Pamela   Wozniak Antoinette   Campbell Angela   Rothermel John   LoRusso Patricia  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.22, Iss.2, 2004-04, pp. : 139-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies

By Cho Cheryl   Fisher George   Halsey Joanne   Sikic Branimir  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies

By Chen Eric   Batist Gerald   Siu Lillian   Bangash Naeema   Maclean Martha   McIntosh Lynn   Miller Wilson   Oza Amit   Lathia Chetan   Petrenciuc Oana   Seymour Lesley  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 455-465

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer

By Burmeister Bryan   Walpole Euan   D’Arcy Nancy   Burmeister Elizabeth   Cox Sharon   Thomson Damien   Harvey Jennifer   Smithers B.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 275-279

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

By Sayar H.   Shen Z.   Lee S.   Royce M.   Rabinowitz I.   Lee F.   Smith H.   Eberhardt S.   Maestas A.   Lu H.   Verschraegen C.  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

By Schwartsmann G.   DiLeone L.   Horowitz M.   Schunemann D.   Cancella A.   Pereira A.   Richter M.   Souza F.   Rocha A.   Souza F.   Pohlmann P.   Nucci G.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 403-412

Springer Publishing Company

Access to resources Recommend Favorite